Navigation Links
New Tool Helps Drug Developers Optimize Their Research and Target Development for Better Results and a Stronger Competitive Edge
Date:6/7/2012

FARMINGTON, Conn., June 4, 2012 /PRNewswire-iReach/ -- Global Information Inc is pleased to announce the immediate availability of a new report and new research tool for cancer drug research and development companies and market analysts:

Oncology Drug Pathway Analyzer

Drug targets and their pathways are the critical link between drugs and their role in the treatment of cancer. The Oncology Drug Pathway Analyzer from BioSeeker Group AB is an interactive data tool to analyze thousands drug-pathway connections in close to 90 different cancer indications. This tool allows users to examine both single pathways and crosstalk between pathways of drugs and filter the included drugs per pathway by twelve drug specific parameters (i.e. Indication, Stage, Company, Molecular function etc.).

With the Oncology Drug Pathway Analyzer, users can review their competition and find suitable benchmarking drugs, basing their search on specific pathways and drug properties. This will allow companies to uncover potential indication expansion areas for their drug portfolios, reveal repositioning opportunities for their older, shelved drugs, and evaluate the progression and success of targeting certain pathways for the treatment of cancer. This tool will also help users investigate different therapy combination options available for various cancer types, and reveal for the most-efficient ways to combine their drugs with other targeted agents.

A detailed description of the tool and a real case scenario are available at http://www.giiresearch.com/report/bg243231-oncology-drug-pathway-analyzer-premium-version.html

Cancer Treatment Drugs Markets in China

As China's continued rise as a modern economy proves to be a significant growth sector, demand for cancer treatment drugs across their nation has grown at a quick pace over the past decade, with both production and demand forecast to continue to this steady growth in the next five years.

Now, Global Information is pleased to make available a collection of 12 complete cancer drug market research reports from Asia Market Information & Development on the Chinese Cancer treatment drugs market, covering the following cancers: lung cancer, breast cancer, prostate cancer, leukemia, ovrian cancer, colon cancer, cevical cancer, brain cancer, bladder cancer, liver cancer, kidney cancer, and skin cancer treatment drugs.

The reports include market trends, developments, with market forecasts through 2016 and 2021.

A summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/amid243405-cancer-treatment-drugs-markets-china-12-full.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia, Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Worlds largest release of comprehensive human cancer genome data helps speed discoveries
2. New musical pacifier helps premature babies get healthy
3. Scripps research scientists find anticonvulsant drug helps marijuana smokers kick the habit
4. Clinical trial launches to see whether vitamin D helps treat multiple sclerosis
5. Gene signature helps identify risk of relapse in lung cancer patients
6. New analysis helps guide use of erlotinib in advanced non-small cell lung cancer
7. University of Minnesota invention helps advance reliability of alternative energy
8. New iPad, iPhone app helps mariners avoid endangered right whales
9. Newly found protein helps cells build tissues
10. Protein jailbreak helps breast cancer cells live
11. Computer sleuthing helps unravel RNAs role in cellular function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... to bring innovative medical technologies, services and solutions to the healthcare market. The ... implementation of various distribution, manufacturing, sales and marketing strategies that are necessary to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: